Roxana Schillaci

Roxana Schillaci

Company: Institute of Biology and Experimental Medicine (IBYME), CONICET

Job title: Principal Researcher

Seminars:

Speaker Q&A 12:40 pm

Read more

day: Innate Immune Checkpoints & Activation Pre-Focus Day

TNFa Blockade Unleashes Innate Tumor Immune Response by Downregulating Mucin 4 & Rendering Anti-HER2 Therapies Effective 11:35 am

The membrane glycoprotein mucin 4 (MUC4) expressed in cancer cells induces an immune-suppressive tumor microenvironment Soluble TNFα blockade with INB03, downregulates MUC4 expression In HER2+ breast cancer INB03 overcomes anti HER2 therapies resistance by downregulating MUC4 expression and unleashing an innate immune responseRead more

day: Innate Immune Checkpoints & Activation Pre-Focus Day

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.